CREATING CONFIDENCE
The proceedings of BioQControl’s pre-IPFA-PEI Workshop in Bologna are now available.
Approximately 70 professionals attended our workshop organized before the main IPFA-PEI meeting in Bologna. Three introductory presentations focused on standardization of testing and a software tool (DataQ Analytics) enabling interlaboratory comparison and statistical evaluation of run control results and other assay performance parameters.
After the break four speakers representing national blood screening laboratories showed performance evaluation and screening data of different assays in relation to residual risk of transfusion-transmitted virus infections. The presenters from Ireland, and South-Africa showed performance data of a new HBV/HCV/HIV/HEV NAT assay and a widely used HIV-Ag/Ab combo assay, while speakers from Poland and The Netherlands gave insight in risk reduction achieved by different individual-donation and minipool NAT options for detection of HBV and HEV.
Presentations at pre-IPFA-PEI Workshop – May 9 in Bologna
Thirty years post-market performance follow-up (PMPF) of NAT and serologic assays for detection of blood borne viruses
|
Nico Lelie, BioQControl, Heiloo, Netherlands |
|
Harry van Drimmelen, BioQControl, Heiloo, Netherlands |
|
Automated assay-specific statistical evaluation of test run results Jos Weusten, Statistician, Nijmegen, the Netherlands |
|
Performance evaluation of Ultrioplex E assay Padraig Williams, Irish Blood Transfusion Service, Dublin, Ireland |
|
Fifteen years of HBV transmission risk reduction by different NAT methods used in Poland Aneta Kopacz, Institute of Hematology and Transfusion Medicine, Warsaw, Poland |
|
Sensitivity of Alinity combo HIV-Ag/Ab assay Josephine Mitchel, South African National Blood Service, Johannesburg, South Africa |
|
HEV-NAT screening update: Effect of screening sensitivity on residual risk Boris Hogema, Sanquin Blood Supply Foundation, Amsterdam, the Netherlands
|
